SOLICITATION NOTICE
A -- Butyrylcholinesterase Expression in Plants - DARPA-BAA-12-31
- Notice Date
- 2/16/2012
- Notice Type
- Presolicitation
- NAICS
- 541712
— Research and Development in the Physical, Engineering, and Life Sciences (except Biotechnology)
- Contracting Office
- Other Defense Agencies, Defense Advanced Research Projects Agency, Contracts Management Office, 3701 North Fairfax Drive, Arlington, Virginia, 22203-1714
- ZIP Code
- 22203-1714
- Solicitation Number
- DARPA-BAA-12-31
- Archive Date
- 6/26/2012
- Point of Contact
- Alan Magill,
- E-Mail Address
-
DARPA-BAA-12-31@darpa.mil
(DARPA-BAA-12-31@darpa.mil)
- Small Business Set-Aside
- N/A
- Description
- DARPA-BAA-12-31 DARPA is seeking innovative research proposals that will demonstrate the ability to produce a recombinant butyrylcholinesterase (rBuChE) using the Nicotiana benthamiana plant-based expression platform that has the same pharmacokinetic profile as a plasma-derived human butyrylcholinesterase (hBuChE) butyrylcholinesterase. The funding is intended to establish the technical precedence for the use of the plant platform to generate a rapid and scalable form of pre-exposure therapeutic bioscavenger against organophosphate nerve agents. Funding is for basic research only. The anticipated period of funding is for 12 months. See attached DARPA-BAA-12-31.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/ODA/DARPA/CMO/DARPA-BAA-12-31/listing.html)
- Record
- SN02677461-W 20120218/120216235213-c6f8cf3a3bb2ac068673b9385fa78d00 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |